Stay updated on AVANOVA: Niraparib vs Niraparib-bevacizumab in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the AVANOVA: Niraparib vs Niraparib-bevacizumab in Ovarian Cancer Clinical Trial page.

Latest updates to the AVANOVA: Niraparib vs Niraparib-bevacizumab in Ovarian Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRecruitment status shows the study is no longer enrolling participants. New help and navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and the Intervention/Treatment header formatting was updated with a revision notice (Revision: v3.6.0).SummaryDifference0.4%

- Check17 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5, representing a small page rendering/update to the ClinicalTrials.gov page.SummaryDifference0.1%

- Check39 days agoChange DetectedThe page revision label was updated from v3.5.3 to v3.5.4, signaling a new release of the site software. This update reflects changes to the page framework or documentation without altering the study content or visible data on the page.SummaryDifference0.1%

- Check60 days agoChange DetectedUpdates the ClinicalTrials.gov page’s footer revision/version from v3.5.0 to v3.5.3, reflecting a platform release rather than study-specific information.SummaryDifference0.1%

- Check96 days agoChange DetectedRevision indicator updated to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.1%

- Check111 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

Stay in the know with updates to AVANOVA: Niraparib vs Niraparib-bevacizumab in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AVANOVA: Niraparib vs Niraparib-bevacizumab in Ovarian Cancer Clinical Trial page.